Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Podcast: Key Takeaways From J.P. Morgan

Executive Summary

Scrip journalists join Datamonitor Healthcare's Mike Ramirez to share their impressions from the 2020 J.P. Morgan conference in San Francisco. Talking points range from M&A to the drug pricing debate, via individual company strategies, the impending US election and more.

In conversation with Datamonitor Healthcare analyst Mike Ramirez, Scrip journalists Jessica Merrill and Andrew McConaghie share their thoughts and observations from the biopharma industry's unofficial annual kick-off event, the J.P. Morgan Healthcare conference. 


Datamonitor Healthcare

Topics covered in this podcast include:

  • Intro/general discussion of the meeting (0:00-4:17)

  • Focus on execution at this year's meeting (4:17-6:14)

  • Companies that may be poised to make M&A deals in the near future (6:14-9:05)

  • Potential reasons behind lack of M&A, inlcuding uncertainty around the US election, valuation expectations (9:05-16:49)

  • Discussion on drug pricing regulation (16:49-23:31)

  • Sessions of particular interest (23:31-34:24)


For additional Informa Pharma Intelligence podcasts, visit





Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts